SFX by Ex Libris Inc.

Title:	Progress in the development of an HIV-1 vaccine
Source:	Science [0036-8075] Letvin, N L yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kwong, Peter D D. "HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites." Nature 420.6916 (2003): 678-82.
description	2.	Wood, D.J. J. "Stopping poliovirus vaccination after eradication: issues and challenges." Bulletin of the World Health Organization 78.3 (2000): 347-357.
description	3.	Maplanka, C. "AIDS: is there an answer to the global pandemic? The immune system in HIV." Viral immunology 20.3 (2007): 331-42.
description	4.	McMichael, Andrew J., T. "HIV vaccines 1983-2003." Nature medicine 9.7 (2003): 874-880.
description	5.	Nathanson, N. "The role of nonhuman primates in the development of an AIDS vaccine." AIDS 13 Suppl A: 113-20.
description	6.	Jardetzky, T. "HIV - Conformational camouflage." Nature 420.6916 (2002): 623-624.
description	7.	Duerr, A. "An Ad5-Vectored HIV-1 Vaccine Elicits Cell-mediated Immunity but does not Affect Disease Progression in HIV-1-infected Male Subjects: Results From a Randomized Placebo-Controlled Trial (The Step Study)." The Journal of infectious diseases 203.6 (2011): 765-772.
description	8.	Wei, George M M. "Antibody neutralization and escape by HIV-1." Nature 422.6929 (2003): 307-312.
description	9.	Letvin, Norman L L. "Progress toward an HIV vaccine." Annual review of medicine 56.1 (2005): 213-23.
description	10.	Salvati, Anna L. "Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus." Antimicrobial agents and chemotherapy 48.6 (2004): 2233-2243.
description	11.	Wright, P.F. F. "Strategies for the global eradication of poliomyelitis by the year 2000." The New England journal of medicine 325.25 (1991): 1774-1779.
description	12.	Westrop, GD. "Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine." Journal of virology 63.3 (1989): 1338-1344.
description	13.	Smith, J. "Certification of polio eradication: process and lessons learned." Bulletin of the World Health Organization 82.1 (2004): 24-30.
description	14.	Rappuoli, R. "Reverse vaccinology, a genome-based approach to vaccine development." Vaccine 19.17 (2001): 2688-91.
description	15.	Norley, S. "Simian immunodeficiency virus as a model of HIV pathogenesis." Springer seminars in immunopathology 18.3: 391-405.
description	16.	Barouch, Dan H H. "Adenovirus vector-based vaccines for human immunodeficiency virus type 1." Human gene therapy 16.2 (2005): 149-56.
description	17.	Little, S J J. "Viral dynamics of acute HIV-1 infection." The Journal of experimental medicine 190.6 (1999): 841-50.
description	18.	Rowland-Jones, S. "HIV: tired T cells turn around." Nature 443.7109 (2006): 282-3.
description	19.	Richman, D.D. D. "HIV chemotherapy." Nature 410.6831 (2001): 995-1001.
description	20.	Manavi, K. "A review on infection with human immunodeficiency virus." Baillière's best practice & research. Clinical obstetrics & gynaecology 20.6 (2006): 923-40.